Waters Corporation P/E ratio

P/E ratio of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/E ratio of Waters Corporation is 29.49 (as of December 30, 2020)
  • P/E ratio for the quarter ending December 30, 2020 was 29.49 (a 21.02% increase compared to previous quarter)
  • Year-over-year quarterly P/E ratio increased by 32.67%
  • Annual P/E ratio for 2020 was 29.49 (a 11.7% increase from previous year)
  • Annual P/E ratio for 2019 was 26.4 (a 8.32% increase from previous year)
  • Annual P/E ratio for 2018 was 24.37 (a -97.01% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of Waters Corporation

Most recent P/E ratioof WAT including historical data for past 10 years.

Interactive Chart of P/E ratio of Waters Corporation

Waters Corporation P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 29.49 24.37 22.33 22.23 29.49
2019 26.4 27.29 27.64 32.27 26.4
2018 24.37 236.59 280.84 576.41 24.37
2017 815.38 26.58 27.48 23.58 815.38
2016 21.09 25.77 23.36 23.1 21.09
2015 23.57 20.81 22.84 22.69 23.57
2014 21.89 19.82 21.8 23.12 21.89
2013 18.98 18.87 18.25 16.5 18.98
2012 16.53 17.61 16.46 19.79 16.53
2011 15.89 16.34 21.13 19.93 15.89
2010 18.77 18.34 17.82 18.77

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.